Stockscreener 앱 받기
331.57
2.68%
-9.12
전일 마감가:
$340.69
열려 있는:
$338.5
하루 거래량:
3.86M
Relative Volume:
1.36
시가총액:
$118.70B
수익:
$11.03B
순이익/손실:
$3.16B
주가수익비율:
38.00
EPS:
8.7254
순현금흐름:
$2.83B
1주 성능:
-17.59%
1개월 성능:
-17.77%
6개월 성능:
-36.72%
1년 성능:
-33.95%
1일 변동 폭
$328.57
$340.55
1주일 범위
$328.57
$367.74
52주 변동 폭
$328.57
$603.88
인튜이티브 서지컬 Stock (ISRG) Company Profile
명칭
Intuitive Surgical Inc
전화
(408) 523-2100
주소
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
331.32 | 122.06B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
152.83 | 42.20B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.14 | 32.85B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.45 | 31.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
191.10 | 27.98B | 5.54B | 1.52B | 1.74B | 10.37 |
인튜이티브 서지컬 Stock (ISRG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-07-23 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-06-09 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2025-06-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | 재확인 | Citigroup | Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-11-17 | 개시 | HSBC Securities | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-19 | 재확인 | BTIG Research | Buy |
| 2023-04-19 | 재확인 | BofA Securities | Buy |
| 2023-04-19 | 재확인 | Citigroup | Buy |
| 2023-04-19 | 재확인 | Evercore ISI | In-line |
| 2023-04-19 | 재확인 | JP Morgan | Overweight |
| 2023-04-19 | 재확인 | Morgan Stanley | Equal-Weight |
| 2023-04-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-04-19 | 재확인 | Raymond James | Outperform |
| 2023-04-19 | 재확인 | Stifel | Buy |
| 2023-04-19 | 재확인 | Truist | Buy |
| 2023-04-19 | 재확인 | Wells Fargo | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-23 | 개시 | William Blair | Outperform |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-13 | 개시 | Mizuho | Neutral |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-25 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | 다운그레이드 | Redburn | Buy → Neutral |
| 2022-01-21 | 재확인 | BTIG Research | Buy |
| 2022-01-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-21 | 재확인 | Deutsche Bank | Hold |
| 2022-01-21 | 재확인 | Evercore ISI | In-line |
| 2022-01-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-01-21 | 재확인 | Piper Sandler | Neutral |
| 2022-01-21 | 재확인 | Raymond James | Outperform |
| 2022-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2022-01-21 | 재확인 | Stifel | Buy |
| 2022-01-21 | 재확인 | UBS | Neutral |
| 2022-01-21 | 재확인 | Wells Fargo | Overweight |
| 2022-01-10 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-07-21 | 재확인 | BofA Securities | Neutral |
| 2021-07-21 | 재확인 | Citigroup | Buy |
| 2021-07-21 | 재확인 | JP Morgan | Overweight |
| 2021-07-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-07-21 | 재확인 | Piper Sandler | Neutral |
| 2021-07-21 | 재확인 | SVB Leerink | Mkt Perform |
| 2021-07-21 | 재확인 | Stifel | Buy |
| 2021-07-21 | 재확인 | UBS | Neutral |
| 2021-07-21 | 재확인 | Wells Fargo | Overweight |
| 2021-07-14 | 재확인 | Goldman | Buy |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-04-21 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2021-04-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2020-12-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | 개시 | Argus | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-07-20 | 재확인 | Bernstein | Outperform |
| 2020-04-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | 다운그레이드 | CFRA | Hold → Sell |
| 2020-04-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-04-01 | 다운그레이드 | Oppenheimer | Perform → Underperform |
| 2020-01-27 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-12-12 | 재확인 | Wells Fargo | Outperform |
| 2019-11-21 | 개시 | Oppenheimer | Perform |
| 2019-07-19 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-22 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-02 | 개시 | Deutsche Bank | Buy |
| 2018-10-31 | 재확인 | Piper Jaffray | Overweight |
| 2018-10-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
모두보기
인튜이티브 서지컬 주식(ISRG)의 최신 뉴스
The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants - Yahoo! Finance Canada
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It? - Yahoo Finance
Intuitive showcases AI for surgical robotics, telesurgery capabilities - MassDevice
Intuitive Shares Vision for an AI-Enabled Future of Healthcare - GlobeNewswire
FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’ - Fierce Biotech
Intuitive Surgical Confronts Rising Risks From Unauthorized da Vinci and Ion Parts and Service - TipRanks
Why Did PEGA, ISRG, MCD Stocks Plunge To 52-Week Lows Today? - Stocktwits
Johnson & Johnson announces its entry into the US robotic surgery market, says it is ready to enter hospi - The Times of India
Intuitive Surgical stock trades steadily as da Vinci procedures grow and margins expand - Ad-hoc-news.de
Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker - Yahoo Finance
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today - Barchart.com
Time runs out for Vicarious Surgical - MedTech Dive
The Wait Is Over: J&J's OTTAVA Surgical Robot Wins FDA Nod, Challenging Intuitive's 80% Market Share - Medical Device and Diagnostic industry
Intuitive Surgical (ISRG) investment analysis: fundamentals vs. technicals after the selloff By Investing.com - Investing.com
Global Robotic Endoscopy Devices Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~10% by 2034 | DelveInsight - GlobeNewswire Inc.
Johnson & Johnson Enters Robotic Surgery Market; Flagship Device Gets FDA Nod - NDTV Profit
Intuitive Surgical stock hits 52-week low at 342.06 USD By Investing.com - Investing.com South Africa
Intuitive Surgical stock hits 52-week low at 342.06 USD - Investing.com India
Intuitive Surgical, Medtronic down as J&J wins FDA nod for surgical robot - Seeking Alpha
ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue - TradingView
ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure - TradingView
Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise - TradingView
J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive - MedTech Dive
J&J MedTech jumps into surgical robot game as OTTAVA secures FDA nod - Medical Device Network
Can ISRG Maintain Its Premium Valuation Amid Slower Procedure Growth? - Yahoo Finance
J&J enters US robotic surgery market after device gets marketing authorization - Reuters
CICC Adjusts Intuitive Surgical Price Target to $389 From $501, Maintains Neutral Rating - marketscreener.com
Conmed’s AirSeal Robotic Solution OK’ed for Intuitive da Vinci 5 Hex Cannula - Medical Product Outsourcing
Johnson & Johnson wins FDA nod for Ottava surgical robot - MassDevice
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal - Business Wire
Even the da Vinci Surgical Robot Has Started to Reduce Costs - 36 Kr
ISRG SWOT Analysis: Strong Financials and Growth Potential Revea - GuruFocus
Intuitive Surgical (ISRG) Files $1.77 Billion ESOP Shelf Registration - simplywall.st
Intuitive Surgical Inc. stock underperforms Friday when compared to competitors - MSN
Intuitive Surgical Inc Q2 2026: Revenue $2.89B, EPS $2.29— 10-Q Summary - TradingView
[10-Q] INTUITIVE SURGICAL INC Quarterly Earnings Report - Stock Titan
Is Intuitive Surgical a Buy After Its Latest Earnings Report? - The Motley Fool
ISRG stock holds steady as Intuitive Surgical awaits fresh catalyst - Ad-hoc-news.de
ISRG Stock: The Math Hidden In Its Price - Trefis
Medtronic adds real-time AI to Hugo robot - MedTech Dive
Here's How Much $100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth Today - Benzinga
Intuitive Surgical (ISRG) Slid Despite Strong Fundamentals - Yahoo Finance
Intuitive Surgical Stock Is Trading at Multi-Year Lows: Is It a Bargain Buy? - The Motley Fool
Intuitive Surgical stock trades near record levels as procedure growth supports earnings - Ad-hoc-news.de
Intuitive Surgical, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ISRG) 2026-07-20 - Seeking Alpha
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
The Robot Maker’s Paradox - Trefis
What’s More Important For Intuitive Surgical: Today’s Robots Or Tomorrow’s Growth? - Trefis
3 Reasons Growth Investors Will Love Intuitive Surgical (ISRG) - Yahoo Finance
Bernstein cuts Intuitive Surgical stock price target on U.S. growth concerns - Investing.com
인튜이티브 서지컬 (ISRG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
인튜이티브 서지컬 주식 (ISRG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 12 '26 |
Sale |
414.13 |
25 |
10,353 |
1,406 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 11 '26 |
Sale |
412.16 |
23 |
9,480 |
1,431 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 10 '26 |
Sale |
424.14 |
23 |
9,755 |
1,454 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 09 '26 |
Sale |
421.13 |
23 |
9,686 |
1,477 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 08 '26 |
Sale |
420.12 |
23 |
9,663 |
1,500 |
| LOEB GARY | EVP & Chief Legal and Complian |
Jun 10 '26 |
Sale |
424.14 |
400 |
169,656 |
5,720 |
0.07%
1.02%
자본화:
|
볼륨(24시간):